Enriqueta Felip
oncology
Vall d'Hebron Institut d’Oncologia
Spain
Biography
Dr. Enriqueta Felip is currently working as a Head of the Thoracic Tumors Group in the Department of Oncology, Vall d'Hebron Institute of Oncology , Spain. His research interests includes  cancer studies,genetic determinations.she is serving as an editorial member and reviewer of several international reputed journals. Dr. Enriqueta Felip is the member of many international affiliations.She has successfully completed his Administrative responsibilities.she has authored of many research articles/books related to  cancer studies,genetic determinations.
Research Interest
Optimization of multidisciplinary treatments Early integration of genetic determinations to personalize treatments Development of new drugs
Publications
-
Cedrés S, Ponce-Aix S, Pardo-Aranda N, Navarro-Mendivil A, Martinez-Marti A, Zugazagoitia J, Sansano I, Montoro MA, Enguita A, Felip E. Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). Lung Cancer. 2016 Jun;96:1-6.
-
Reck M, Luft A, Szczesna A, Havel L, Kim SW, Akerley W, Pietanza MC, Wu YL, Zielinski C, Thomas M, Felip E, Gold K, Horn L, Aerts J, Nakagawa K, Lorigan P, Pieters A, Kong Sanchez T, Fairchild J, Spigel D. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer. J Clin Oncol. 2016 Jul 25. pii: JCO676601. [Epub ahead of print]
-
Solomon BJ, Cappuzzo F, Felip E, Blackhall FH, Costa DB, Kim DW, Nakagawa K, Wu YL, Mekhail T, Paolini J, Tursi J, Usari T, Wilner KD, Selaru P, Mok TS. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014. J Clin Oncol. 2016 Aug 20;34(24):2858-65.
